Lactobacillus plantarum strain LP-29
Scientific and Clinical Studies
TruFloraTM Probiotic Strains
Lactobacillus Plantarum strain LP-29 (also called LP-115) present in TruFloraTM at 10 Billion CFU Per Capsule
References:
Deposited at the American Type Culture Collection (ATCC) as SD5209.
Mogensen, G., Salminen, S., O’Brien, J., Ouwehand, A.C., Holzapfel, W., Shortt, C., Fonden, R., Miller, G.D., Donohue, D., Playne, M., Crittenden, R., Salvadori, B. & Zinc, R. (2002). Inventory of microorganisms with a documented history of safe use in food. Bulletin of the International Dairy Federation. 377:10-19.
Daniel, C., Poiret, S., Goudercourt, D., Dennin, V., Leyer, G. & Pot, B. (2006). Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model. Applied and Environmental Microbiology. 72(9):5799-5805.
Collado, M.C., Meriluoto, J. & Salminen, S. (2007). Adhesion and aggregation properties of probiotic and pathogenic strains. Eur Food Res Technol. DOI 10.1007/s00217-007-0632-x.
Collado, M.C, Meriluoto, J. & Salminen, S. (2007). Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Letters in Applied Microbiology. oi:10.1111/j.1472-765X.2007.02212.x.
Turroni, S., Vitali, B., Bendazzoli, C., Candela, M., Gotti, R., Federci, F., Pirovano, F. & Brigidi, P. (2007). Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus. Journal of Applied Microbiology (OnlineEarly Articles). Doi:10.1111/j.1365-2672.2007.03388.x.
Foligne, B., Nutten, S., Grangette, C., Dennin, V., Goudercourt, D., Poiret, S., Dewulf, J., Brassart, D., Merceneir, A. & Pot, B. (2007). Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World Journal of Gastroenterology 13(2):236-243.
Lactobacillus salivarius strain LS-30
Scientific and Clinical Studies
TruFloraTM Probiotic Strains
Lactobacillus salivarius strain LS-30 (also called Ls-33) present in TruFloraTM at 3 Billion CFU Per Capsule
References:
Deposited at the American Type Culture Collection (ATCC) as SD5208.
Mogensen, G., Salminen, S., O’Brien, J., Ouwehand, A.C., Holzapfel, W., Shortt, C., Fonden, R., Miller, G.D., Donohue, D., Playne, M., Crittenden, R., Salvadori, B. & Zinc, R. (2002). Inventory of microorganisms with a documented history of safe use in food. Bulletin of the International Dairy Federation. 377:10-19.
Daniel, C., Poiret, S., Goudercourt, D., Dennin, V., Leyer, G. & Pot, B. (2006). Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model. Applied and Environmental Microbiology. 72(9):5799-5805.
Collado, M.C., Meriluoto, J. & Salminen, S. (2007). Adhesion and aggregation properties of probiotic and pathogenic strains. Eur Food Res Technol. DOI 10.1007/s00217-007-0632-x.
Collado, M.C, Meriluoto, J. & Salminen, S. (2007). Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Letters in Applied Microbiology. Doi:10.1111/j.1472-765X.2007.02212.x.
Fogligne, B., Nutten, S., Grangette, C., Dennin, V., Goudercourt, D., Poiret, S., Dewulf, J., Brassart, D., Mercenier, A. & Pot, B. (2007). Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World Journal of Gastroenterology. 13(2):236-243.
Foligne, B., Zoumpopoulou, G., Dewulf, J., Ben Younes, A., Chareyre, F., et al. (2007). A Key Role of Dendritic Cells in Probiotic Functionality. PloS ONE 2(3):e313.doi:10.1371/journal.pone.0000313.